दवाओं की अंतःक्रिया
Betibeglogene autotemcel + Deferoxamine
गंभीरता: गंभीर
Betibeglogene autotemcel and Deferoxamine: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Some iron chelators can suppress bone marrow and may interfere with engraftment and hematologic recovery after gene therapy conditioning. Chelation around the time of myeloablation and infusion is therefore restricted.
इस इंटरैक्शन का सरल भाषा में अर्थ
Betibeglogene autotemcel and Deferoxamine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
ऐसा क्यों होता है
Potential additive myelosuppressive or marrow-impairing effects of chelators could compromise engraftment; deferoxamine itself is less myelosuppressive than some chelators, so the mechanism is not firmly established.
क्या करें
Stop iron chelation at least 7 days before conditioning, and avoid myelosuppressive chelators for about 6 months after infusion. Use phlebotomy or a non-myelosuppressive chelator if iron reduction is needed.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Betibeglogene autotemcel और Deferoxamine की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 7 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Deferoxamine के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Betibeglogene autotemcel with Deferoxamine?
MediHelp rates the interaction as major. Betibeglogene autotemcel and Deferoxamine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Some iron chelators can suppress bone marrow and may interfere with engraftment and hematologic recovery after gene therapy conditioning. Chelation around the time of myeloablation and infusion is therefore restricted.
How serious is the interaction between Betibeglogene autotemcel and Deferoxamine?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop iron chelation at least 7 days before conditioning, and avoid myelosuppressive chelators for about 6 months after infusion. Use phlebotomy or a non-myelosuppressive chelator if iron reduction is needed.
What other medicines interact with Deferoxamine?
MediHelp also lists interactions of Deferoxamine with, for example, Ascorbic acid, Exagamglogene autotemcel, Lovotibeglogene autotemcel. The full list is on the Deferoxamine page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
